Coherus BioSciences, Inc. (CHRS) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-10

Coherus BioSciences, Inc. (CHRS) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-10. 3 Form 8-K material event filings were reported by CHRS in the last 90 days. InsiderAlpha tracks every CHRS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Coherus BioSciences, Inc. (CHRS)

SEC CIK	0001512762

90-Day SEC Filing Activity

Form 4 filings (90d)	9
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-10

Recent CHRS Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-05	Satvat Ali J.	Insider	A — Grant or award	30.0K	$0.00	—	SEC
2026-06-05	Newcomer Lee Nisley	Insider	A — Grant or award	30.0K	$0.00	—	SEC
2026-06-05	Ryan Michael Lee	Insider	A — Grant or award	30.0K	$0.00	—	SEC
2026-06-05	O'Donnell-Tormey Jill	Insider	A — Grant or award	30.0K	$0.00	—	SEC
2026-06-05	Wahlstrom Mats	Insider	A — Grant or award	30.0K	$0.00	—	SEC
2026-06-05	Newton Charles W.	Insider	A — Grant or award	30.0K	$0.00	—	SEC
2026-06-05	Karachun Rita A	Insider	A — Grant or award	30.0K	$0.00	—	SEC
2026-01-23	Lanfear Dennis M	President & CEO	A — Grant or award	375.0K	$0.00	—	SEC
2026-01-22	McMichael Bryan J	Chief Financial Officer	A — Grant or award	112.5K	$0.00	—	SEC
2026-01-20	McMichael Bryan J	Chief Financial Officer	F — Tax withholding / forfeiture	1.7K	$1.55	$3K	SEC
2026-01-20	Lanfear Dennis M	President & CEO	F — Tax withholding / forfeiture	11.8K	$1.55	$18K	SEC
2024-12-13	Reider Paul	Chief Commercial Officer	F — Tax withholding / forfeiture	2.1K	$1.61	$3K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Coherus BioSciences, Inc. (CHRS). Updated in real time as new filings are submitted to the SEC.

Most-Active CHRS Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Lanfear Dennis M	18	—
McMichael Bryan J	12	—
Satvat Ali J.	2	—
Newcomer Lee Nisley	2	—
Karachun Rita A	2	—

Recent CHRS Form 8-K Material Events

2026-06-15 — Item 4.01, 9.01 [SEC]
2026-06-01 — Item 5.07 [SEC]
2026-05-11 — Item 2.02, 9.01 [SEC]
2026-03-09 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Coherus Oncology issued a press release on March 9, 2026 reporting financial results for Q4 2025 and fiscal year 2025. The filing provides standard financial results disclosure without indication of beat/miss relative to expectations.
2026-02-17 — Item 8.01, 9.01 · Financing · negative [SEC]
Coherus Oncology completed a public equity offering of 28.6 million shares at $1.75 per share, raising approximately $47.0 million in net proceeds. This represents significant dilution to existing shareholders and suggests the company needed capital, potentially indicating financ

Recent Insider Filings

2026-06-10 — Satvat Ali J. (Insider)
2026-06-09 — Karachun Rita A (Insider)
2026-06-09 — Newcomer Lee Nisley (Insider)
2026-06-09 — Ryan Michael Lee (Insider)
2026-06-09 — O'Donnell-Tormey Jill (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CHRS insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CHRS Insider Trading — FAQ

What is the latest insider trade for CHRS?: Coherus BioSciences, Inc. (CHRS) had 9 insider filings in the last 90 days, with the most recent on 2026-06-10. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CHRS stock?: 0 insider purchases of CHRS were filed in the last 90 days.
How many insiders are selling CHRS stock?: 0 insider sales of CHRS were filed in the last 90 days.
Where can I see CHRS SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CHRS SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CHRS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.